EXPRESSION PROFILES OF DRUG-METABOLIZING ENZYME CYP3A AND DRUG EFFLUX TRANSPORTER MULTIDRUG RESISTANCE 1 SUBFAMILY mRNAS IN RAT SMALL INTESTINE
Authors:
- Kohji TakaraKTKohji Takara
- Noriaki OhnishiNONoriaki Ohnishi
- Sayo HoribeSHSayo Horibe
- Teruyoshi YokoyamaTYTeruyoshi Yokoyama
- 1 October 2003
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 31 (10) , 1235-1239
Abstract
The purpose of this study is to examine the expression profiles of CYP3A1, CYP3A2, CYP3A9, and CYP3A18 mRNAs as well as multidrug resistance (mdr)1a and mdr1b mRNAs in the liver and small intestine of normal male Wistar rats using a reverse transcription-polymerase chain reaction (PCR). In the rat liver, the PCR products for CYP3A1, CYP3A2, and CYP3A18 were readily detectable, whereas CYP3A9 was slightly and mdr1a and mdr1b barely detected. Surprisingly, no PCR products for CYP3A1 and CYP3A2 were detected in the small intestine, but those for CYP3A9, CYP3A18, and mdr1a were readily detectable, and a faint band for mdr1b was also observed. Both CYP3A9 and CYP3A18 levels were found to be high in the duodenum and decreased from the top to bottom of the gut, indicating regional differences in both CYP3A9 and CYP3A18 expression in the small intestine. In contrast, mdr1a expression increased gradually from the upper to lower intestine. Consequently, it was suggested that drug metabolism in the small intestine of normal rats was mediated by CYP3A9 and CYP3A18 rather than CYP3A1 and CYP3A2. Also, regional differences of CYP3A9, CYP3A18, and mdr1a expression were found in the small intestine. The distributions of CYP3A9 and CYP3A18 were different from the distribution of mdr1a, suggesting the cooperative action of drug clearance pathways. This information is important to drug metabolism research based on ex vivo and in vivo studies using rats.Keywords
This publication has 29 references indexed in Scilit:
- Human Extrahepatic Cytochromes P450: Function in Xenobiotic Metabolism and Tissue-Selective Chemical Toxicity in the Respiratory and Gastrointestinal TractsAnnual Review of Pharmacology and Toxicology, 2003
- The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humansAdvanced Drug Delivery Reviews, 2002
- Selective induction of cytochrome P450 3A1 by dexamethasone in cultured rat hepatocytesBiochemical Pharmacology, 2000
- A Novel Cytochrome P450 3A Isoenzyme in Rat Intestinal MicrosomesBiochemical and Biophysical Research Communications, 1999
- Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes: Major role of CYP3ABiochemical Pharmacology, 1997
- cDNA Cloning and Characterization of a Novel Member of Steroid-Induced Cytochrome P450 3A in RatsArchives of Biochemistry and Biophysics, 1993
- Analysis of segmental phosphate absorption in intact rats. A compartmental analysis approach.Journal of Clinical Investigation, 1993
- Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammalsPharmacology & Therapeutics, 1993
- Heterogeneity of cytochrome P450IIIA expression in rat gut epitheliaGastroenterology, 1992
- Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation.Molecular and Cellular Biology, 1986